Bluebird Bio (BLUE, Financial) experienced a significant drop in its stock price, declining by 5.67%. The shares are currently trading at 0.491,withatradingvolumeof3.72millionshares,aturnoverrateof1.9216.10 million in revenue, with a net loss of 81.39million.Theearningspershare(EPS)standat−0.42, and the gross profit is reported at -$12.85 million. The price-to-earnings (P/E) ...